Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy

por Pelzer, Uwe, Hilbig, Andreas, Sinn, Marianne, Stieler, Jens, Bahra, Marcus, Dörken, Bernd, Riess, Hanno
Publicado 2013

Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer – the CONKO 004 pilot trial

por Pelzer, Uwe, Hilbig, Andreas, Stieler, Jens M, Bahra, Marcus, Sinn, Marianne, Gebauer, Bernhard, Dörken, Bernd, Riess, Hanno
Publicado 2014

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)

por Riess, Hanno, Pelzer, Uwe, Hilbig, Andreas, Stieler, Jens, Opitz, Bernhard, Scholten, Theo, Kauschat-Brüning, Dörte, Bramlage, Peter, Dörken, Bernd, Oettle, Helmut
Publicado 2008